A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT03987919
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tirzepatide — DRUGAdministered SC
- Semaglutide — DRUGAdministered SC
Study Details
The reason for this study is to compare the effect of the study drug tirzepatide to semaglutide on blood sugar levels in participants with type 2 diabetes. The study will last approximately 47 weeks and may include about 12 visits.
Key Dates
- Start date
- Jul 30, 2019
- Status verified
- Jul 2021
- Primary completion
- Jan 28, 2021
- Completion
- Feb 15, 2021
Study Design
- Enrollment
- 1,879 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 5 mg Tirzepatide5 milligrams (mg) tirzepatide administered subcutaneously (SC) once a week.
- Experimental: 10 mg Tirzepatide10 mg tirzepatide administered SC once a week.
- Experimental: 15 mg Tirzepatide15 mg tirzepatide administered SC once a week.
- Active Comparator: 1 mg Semaglutide1 mg semaglutide administered SC once a week.
Primary Outcome Measure
Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg) [ Time Frame: Baseline, Week 40 ]
Locations (51)
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Sleep and Glycemic Control in Type 2 Diabetes AdolescentsRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)Recruiting · Children's Hospital Los Angeles · Los Angeles, California